[go: up one dir, main page]

CN116516575B - Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application - Google Patents

Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application Download PDF

Info

Publication number
CN116516575B
CN116516575B CN202310800257.4A CN202310800257A CN116516575B CN 116516575 B CN116516575 B CN 116516575B CN 202310800257 A CN202310800257 A CN 202310800257A CN 116516575 B CN116516575 B CN 116516575B
Authority
CN
China
Prior art keywords
curcumin
resveratrol
nanofiber membrane
protein
zcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202310800257.4A
Other languages
Chinese (zh)
Other versions
CN116516575A (en
Inventor
张�浩
兰天彤
薛瑾
刘景圣
顾瑾
钱圣
宋亭喻
吴玉柱
许秀颖
赵城彬
付大平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Agricultural University
Original Assignee
Jilin Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Agricultural University filed Critical Jilin Agricultural University
Priority to CN202310800257.4A priority Critical patent/CN116516575B/en
Publication of CN116516575A publication Critical patent/CN116516575A/en
Application granted granted Critical
Publication of CN116516575B publication Critical patent/CN116516575B/en
Priority to ZA2024/04467A priority patent/ZA202404467B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/62Compostable, hydrosoluble or hydrodegradable materials
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/28Formation of filaments, threads, or the like while mixing different spinning solutions or melts during the spinning operation; Spinnerette packs therefor
    • D01D5/30Conjugate filaments; Spinnerette packs therefor
    • D01D5/34Core-skin structure; Spinnerette packs therefor
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/10Other agents for modifying properties
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F8/00Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
    • D01F8/02Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from cellulose, cellulose derivatives, or proteins
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F8/00Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
    • D01F8/04Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
    • D01F8/16Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one other macromolecular compound obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds as constituent
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/40Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
    • D04H1/42Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
    • D04H1/4382Stretched reticular film fibres; Composite fibres; Mixed fibres; Ultrafine fibres; Fibres for artificial leather
    • D04H1/43825Composite fibres
    • D04H1/43828Composite fibres sheath-core
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Textile Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Artificial Filaments (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明公开了姜黄素‑白藜芦醇蛋白基纳米纤维膜及其制备方法与应用,涉及纳米纤维材料领域。本发明提出的姜黄素‑白藜芦醇蛋白基纳米纤维膜,采用大豆分离蛋白和玉米醇溶蛋白进行了混合纺丝,将两种溶解性不同的蛋白制备得到了纳米纤维膜形态的稳定蛋白基聚集体。通过同轴静电纺丝制成的纳米纤维膜SPI+25%ZCR、25%Z+25%ZCR、30%Z+30%ZCR表现出了较为优异的自由基清除能力,并且SPI+25%ZCR更为优异,抗菌效果也更加显著,在模拟体外释放时也表现出缓慢稳定的释放速度,性能更为优异,确保大豆分离蛋白纤维薄膜在治疗创伤方面具有广阔的应用前景。

The invention discloses a curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application, and relates to the field of nanofiber materials. The curcumin-resveratrol protein-based nanofiber membrane proposed by the present invention uses soy protein isolate and zein for mixed spinning, and prepares two proteins with different solubility to obtain a stable protein in the form of a nanofiber membrane. base aggregate. Nanofiber membranes SPI+25%ZCR, 25%Z+25%ZCR, and 30%Z+30%ZCR made by coaxial electrospinning show excellent free radical scavenging capabilities, and SPI+25%ZCR It is more excellent and has more significant antibacterial effect. It also shows a slow and stable release rate when simulating in vitro release, and its performance is even better, ensuring that the soy protein isolate fiber film has broad application prospects in treating wounds.

Description

姜黄素-白藜芦醇蛋白基纳米纤维膜及其制备方法与应用Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application

技术领域Technical field

本发明涉及纳米纤维材料领域,尤其涉及姜黄素-白藜芦醇蛋白基纳米纤维膜及其制备方法与应用。The present invention relates to the field of nanofiber materials, and in particular to curcumin-resveratrol protein-based nanofiber membranes and preparation methods and applications thereof.

背景技术Background technique

姜黄素(Cur,本发明中简写为C)是一种极具活力的多酚化合物,它来自于姜黄的根部,具有极低的分子量。它具有抗炎、抗氧化、抗肿瘤和抗血管生成等许多生物活性。并且姜黄素对人类非常安全,即使在高剂量下也无毒。然而,和很多其他的疏水性活性物质相同,姜黄素也存在着一些问题严重影响了它的实际应用,如水溶性差、化学结构不稳定性以及口服生物利用度低等问题,导致其在食品和制药行业的应用受到限制。Curcumin (Cur, abbreviated as C in the present invention) is an extremely active polyphenolic compound, which comes from the roots of turmeric and has an extremely low molecular weight. It has many biological activities such as anti-inflammatory, antioxidant, anti-tumor and anti-angiogenesis. And curcumin is very safe for humans and non-toxic even at high doses. However, like many other hydrophobic active substances, curcumin also has some problems that seriously affect its practical application, such as poor water solubility, unstable chemical structure, and low oral bioavailability, resulting in its use in food and Applications in the pharmaceutical industry are limited.

食物蛋白作为天然的生物活性载体,是蛋白质基纳米体系的理想材料。食品级材料制备的复合纳米粒子已被广泛用于包封和递送生物活性物质。大豆分离蛋白(Spi)是食品工业中应用最广泛的植物蛋白,具有较高的可接受性,已被用于装载β-类胡萝卜素、香兰素、白藜芦醇等活性物质。每种活性物质的负载率在很大程度上取决于蛋白质的性质。由此可见,大豆分离蛋白的结构在很大程度上影响了蛋白-姜黄素颗粒的形成。大豆分离蛋白具有显著的疏水氨基酸、极性基团和带电基团的组成,因此它能够通过疏水相互作用、氢键作用和静电相互作用,有效地促进小生物的活性。As a natural bioactive carrier, food protein is an ideal material for protein-based nanosystems. Composite nanoparticles prepared from food-grade materials have been widely used to encapsulate and deliver bioactive substances. Soy protein isolate (Spi) is the most widely used plant protein in the food industry. It has high acceptability and has been used to load active substances such as β-carotenoids, vanillin, and resveratrol. The loading rate of each active substance depends largely on the nature of the protein. It can be seen that the structure of soy protein isolate greatly affects the formation of protein-curcumin particles. Soy protein isolate has a significant composition of hydrophobic amino acids, polar groups and charged groups, so it can effectively promote the activity of small organisms through hydrophobic interactions, hydrogen bonding interactions and electrostatic interactions.

由于大豆分离蛋白的可再生特性,它们的来源范围广泛,营养丰富,价格实惠,且具有优异的加工性能,如成膜性、空气阻隔性等,使得它们所制备的材料具有极佳的生物兼容性和可降解性,从而为食品包装和医疗领域带来了巨大的发展潜力。然而,由于大豆分离蛋白中还含有大量的亲水基团,使得蛋白质材料的亲水性极强,从而导致其容易被降解、抗水性较弱、机械强度较低等缺陷。Due to the renewable properties of soy protein isolates, they have a wide range of sources, are rich in nutrients, are affordable, and have excellent processing properties, such as film-forming properties, air barrier properties, etc., making the materials prepared from them extremely biocompatible properties and degradability, thus bringing huge development potential to the food packaging and medical fields. However, because soy protein isolate also contains a large number of hydrophilic groups, the protein material is extremely hydrophilic, resulting in defects such as easy degradation, weak water resistance, and low mechanical strength.

玉米醇溶蛋白(Zein,本发明中简写为Z)的纳米递送系统是当前的热门研究方向之一。玉米醇溶蛋白是玉米加工的副产物之一,占据了玉米颗粒蛋白质含量的一半左右。该蛋白质具有疏水性,可以在60%至90%的乙醇水溶液中溶解。Zein的等电点(IEP)为6.2,当溶液的pH值低于IEP时,Zein带正电荷。与此相反,当阴离子多糖在溶液的pH值高于其自身的pKa时,带负电荷。因此,在特定的pH范围内,它们可以具有相反的电荷,从而通过静电相互作用形成复合物。然而,当暴露于某些环境条件(例如等电点附近的pH值、高盐水平和升高的温度)时,玉米醇溶蛋白纳米颗粒具有较差的聚集稳定性。The nanodelivery system of zein (Zein, abbreviated as Z in the present invention) is one of the current hot research directions. Zein is one of the by-products of corn processing and accounts for about half of the protein content of corn kernels. The protein is hydrophobic and can be dissolved in 60% to 90% ethanol aqueous solution. The isoelectric point (IEP) of Zein is 6.2. When the pH of the solution is lower than the IEP, Zein is positively charged. In contrast, anionic polysaccharides become negatively charged when the pH of the solution is higher than their own pKa. Therefore, within a specific pH range, they can have opposite charges, forming complexes through electrostatic interactions. However, zein nanoparticles have poor aggregation stability when exposed to certain environmental conditions such as pH near the isoelectric point, high salt levels, and elevated temperatures.

通过静电纺丝技术制备的蛋白质纤维薄膜具有极高的比表面积和孔隙率,这使得它们在理化条件下更容易被分解和降解,从而为创伤敷料领域的应用提供了巨大的潜力。Protein fiber films prepared by electrospinning technology have extremely high specific surface area and porosity, which makes them easier to decompose and degrade under physical and chemical conditions, thus providing great potential for applications in the field of wound dressings.

此外,目前包含多种生物活性成分的组合存在更好的稳定性或生物活性,而单一组分的则较差,如在乳液中共包封Res和生育酚(α-TOC),不仅提高了α-TOC的化学稳定性,而且其生物可利用性也得到了一定的提高。白藜芦醇(Res,本发明中简写为R),3-5-4'-三羟基-二苯乙烯,是一种非黄酮类多酚化合物,具有潜在的健康益处,包括抗癌、抗炎、抗肥胖和保护心脏、大脑的作用。因此,开发多种不同的生物活性成分可以产生重要的社会效益和经济效益。In addition, current combinations containing multiple bioactive ingredients have better stability or bioactivity, while single components are poorer. For example, co-encapsulation of Res and tocopherol (α-TOC) in emulsions not only improves α -TOC's chemical stability and bioavailability have also been improved to a certain extent. Resveratrol (Res, abbreviated as R in the present invention), 3-5-4'-trihydroxy-stilbene, is a non-flavonoid polyphenol compound with potential health benefits, including anti-cancer, inflammation, anti-obesity and protective effects on the heart and brain. Therefore, the development of a variety of different bioactive ingredients can yield important social and economic benefits.

本发明通过同轴静电纺丝技术分别制备了共包埋姜黄素和白藜芦醇的玉米醇溶蛋白基纳米纤维膜和大豆分离蛋白基纳米纤维膜,并对制得的纳米纤维膜的微观结构、形貌、机械性能、热性能和功能特性进行了表征和分析,探讨不同蛋白基对纳米纤维膜性能的影响,为活性包装领域的应用提供可行方案。The present invention prepares zein-based nanofiber membranes and soy protein isolate-based nanofiber membranes co-embedding curcumin and resveratrol through coaxial electrospinning technology, and analyzes the microscopic properties of the prepared nanofiber membranes. The structure, morphology, mechanical properties, thermal properties and functional properties were characterized and analyzed to explore the effects of different protein bases on the properties of nanofiber membranes and provide feasible solutions for applications in the field of active packaging.

发明内容Contents of the invention

本发明的目的是提出姜黄素-白藜芦醇蛋白基纳米纤维膜及其制备方法与应用。The purpose of the present invention is to propose a curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application.

为了实现上述目的,本发明的技术方案如下:In order to achieve the above objects, the technical solutions of the present invention are as follows:

第一方面,本发明提出的姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,将大豆分离蛋白和聚氧化乙烯混合溶液作为壳液,将添加姜黄素和白藜芦醇的玉米醇溶蛋白溶液作为核液,壳液和核液通过同轴静电纺丝得到姜黄素-白藜芦醇蛋白基纳米纤维膜。In the first aspect, the present invention proposes a method for preparing a curcumin-resveratrol protein-based nanofiber membrane, using a mixed solution of soy protein isolate and polyethylene oxide as the shell liquid, and adding curcumin and resveratrol to zein alcohol. The protein-soluble solution was used as the core liquid, and the shell liquid and core liquid were coaxially electrospun to obtain curcumin-resveratrol protein-based nanofiber membranes.

优选地,上述的姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,包括以下步骤:Preferably, the above-mentioned preparation method of curcumin-resveratrol protein-based nanofiber membrane includes the following steps:

S1、以85%的乙醇水溶液为溶剂,分别制备25 wt%的大豆分离蛋白溶液和13 wt%的聚氧化乙烯溶液,将25 wt%的大豆分离蛋白溶液和13 wt%的聚氧化乙烯溶液按照质量比1:1混合,搅拌使溶液混合均匀作为壳液;S1. Use 85% ethanol aqueous solution as the solvent to prepare 25 wt% soy protein isolate solution and 13 wt% polyoxyethylene solution respectively. Add the 25 wt% soy protein isolate solution and 13 wt% polyoxyethylene solution according to the Mix at a mass ratio of 1:1 and stir until the solution is evenly mixed and used as shell liquid;

S2、制备25 wt%玉米醇溶蛋白溶液,向其中添加姜黄素和白藜芦醇,姜黄素和白藜芦醇的添加量均为10 mg/ml,搅拌使溶液混合均匀作为核液;S2. Prepare a 25 wt% zein solution, add curcumin and resveratrol to it, the added amounts of curcumin and resveratrol are both 10 mg/ml, and stir until the solution is evenly mixed to serve as a nuclear liquid;

S3、将壳液和核液进行同轴静电纺丝,得到姜黄素-白藜芦醇蛋白基纳米纤维膜,记为25%Z+25%ZCR。S3. Perform coaxial electrospinning of the shell liquid and core liquid to obtain a curcumin-resveratrol protein-based nanofiber membrane, recorded as 25%Z+25%ZCR.

优选地,上述的姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,包括以下步骤:Preferably, the above-mentioned preparation method of curcumin-resveratrol protein-based nanofiber membrane includes the following steps:

S1、以85%的乙醇水溶液为溶剂,分别制备30 wt%的大豆分离蛋白溶液和13 wt%的聚氧化乙烯溶液,将30 wt%的大豆分离蛋白溶液和13 wt%的聚氧化乙烯溶液按照质量比1:1混合,搅拌使溶液混合均匀作为壳液;S1. Use 85% ethanol aqueous solution as the solvent to prepare 30 wt% soy protein isolate solution and 13 wt% polyoxyethylene solution respectively. Add the 30 wt% soy protein isolate solution and 13 wt% polyoxyethylene solution according to the Mix at a mass ratio of 1:1 and stir until the solution is evenly mixed and used as shell liquid;

S2、制备30 wt%玉米醇溶蛋白溶液,向其中添加姜黄素和白藜芦醇,姜黄素和白藜芦醇的添加量均为10 mg/ml,搅拌使溶液混合均匀作为核液;S2. Prepare a 30 wt% zein solution, add curcumin and resveratrol to it, the added amounts of curcumin and resveratrol are both 10 mg/ml, and stir until the solution is evenly mixed to serve as a core liquid;

S3、将壳液和核液进行同轴静电纺丝,得到姜黄素-白藜芦醇蛋白基纳米纤维膜,记为30%Z+30%ZCR。S3. Perform coaxial electrospinning of the shell liquid and core liquid to obtain a curcumin-resveratrol protein-based nanofiber membrane, recorded as 30%Z+30%ZCR.

优选地,上述的姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,包括以下步骤:Preferably, the above-mentioned preparation method of curcumin-resveratrol protein-based nanofiber membrane includes the following steps:

S1、以六氟异丙醇为溶剂,制备大豆分离蛋白:聚氧化乙烯质量比为4:1的溶液,超声搅拌使溶液充分溶解作为壳液,记为SPI;S1. Use hexafluoroisopropanol as the solvent to prepare a solution with a mass ratio of soy protein isolate:polyethylene oxide of 4:1. Stir ultrasonically to fully dissolve the solution as a shell liquid, which is recorded as SPI;

S2、制备25 wt%玉米醇溶蛋白溶液,向其中添加姜黄素和白藜芦醇,姜黄素和白藜芦醇的添加量均为10 mg/ml,搅拌使溶液混合均匀作为核液;S2. Prepare a 25 wt% zein solution, add curcumin and resveratrol to it, the added amounts of curcumin and resveratrol are both 10 mg/ml, and stir until the solution is evenly mixed to serve as a nuclear liquid;

S3、将壳液和核液进行同轴静电纺丝,得到姜黄素-白藜芦醇蛋白基纳米纤维膜,记为SPI+25%ZCR。S3. Perform coaxial electrospinning of the shell liquid and core liquid to obtain a curcumin-resveratrol protein-based nanofiber membrane, which is recorded as SPI+25%ZCR.

优选地,上述的姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,步骤S1中,大豆分离蛋白和聚氧化乙烯按照质量比为4:1。Preferably, in the above-mentioned preparation method of curcumin-resveratrol protein-based nanofiber membrane, in step S1, the mass ratio of soy protein isolate and polyethylene oxide is 4:1.

优选地,上述的姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,同轴静电纺丝的参数设置为:壳液流速5 mL/h,核液流速2 mL/h,纺丝时间1 h,电压25 kv,转速1500 r/min,接收距离13 cm,环境温度为25±2℃,湿度为50±5%。Preferably, in the above-mentioned preparation method of curcumin-resveratrol protein-based nanofiber membrane, the parameters of coaxial electrospinning are set to: shell liquid flow rate 5 mL/h, core liquid flow rate 2 mL/h, spinning time 1 h, voltage 25 kv, rotation speed 1500 r/min, receiving distance 13 cm, ambient temperature 25±2℃, humidity 50±5%.

第二方面,本发明还提出姜黄素-白藜芦醇蛋白基纳米纤维膜,采用上述任一项的方法制成。In a second aspect, the present invention also proposes a curcumin-resveratrol protein-based nanofiber membrane, which is prepared by any of the above methods.

第三方面,本发明还提出姜黄素-白藜芦醇蛋白基纳米纤维膜在创伤敷料方面的应用。In a third aspect, the present invention also proposes the application of curcumin-resveratrol protein-based nanofiber membrane in wound dressings.

与现有技术相比,本发明的技术效果:Compared with the existing technology, the technical effects of the present invention are:

本发明提出的姜黄素-白藜芦醇蛋白基纳米纤维膜,采用大豆分离蛋白和玉米醇溶蛋白进行了混合纺丝,将两种溶解性不同的蛋白制备得到了纳米纤维膜形态的稳定蛋白基聚集体。通过同轴静电纺丝制成的纳米纤维膜SPI+25%ZCR、25%Z+25%ZCR、30%Z+30%ZCR表现出了较为优异的自由基清除能力,并且SPI+25%ZCR更为优异,抗菌效果也更加显著,在模拟体外释放时也表现出缓慢稳定的释放速度,性能更为优异,确保大豆分离蛋白纤维薄膜在治疗创伤方面具有广阔的应用前景。The curcumin-resveratrol protein-based nanofiber membrane proposed by the present invention uses soy protein isolate and zein for mixed spinning, and prepares two proteins with different solubility to obtain a stable protein in the form of a nanofiber membrane. base aggregate. Nanofiber membranes SPI+25%ZCR, 25%Z+25%ZCR, and 30%Z+30%ZCR made by coaxial electrospinning show excellent free radical scavenging capabilities, and SPI+25%ZCR It is more excellent and has more significant antibacterial effect. It also shows a slow and stable release rate when simulating in vitro release, and its performance is even better, ensuring that the soy protein isolate fiber film has broad application prospects in treating wounds.

附图说明Description of drawings

图1为本发明实施例提供的单轴条件下纳米纤维膜的扫描电镜图。图中,A 为大豆分离蛋白和聚氧化乙烯按照质量比为4:1的纤维膜,记为SPI,B 为25%Z。Figure 1 is a scanning electron microscope image of a nanofiber membrane under uniaxial conditions provided by an embodiment of the present invention. In the figure, A is a fiber membrane made of soy protein isolate and polyethylene oxide with a mass ratio of 4:1, recorded as SPI, and B is 25%Z.

图2为本发明实施例提供的同轴条件下纳米纤维膜的扫描电镜图。图中,C为25%Z+25%ZCR,D为30%Z+30%ZCR,E为SPI+25%ZCR。Figure 2 is a scanning electron microscope image of the nanofiber membrane under coaxial conditions provided by the embodiment of the present invention. In the figure, C is 25%Z+25%ZCR, D is 30%Z+30%ZCR, and E is SPI+25%ZCR.

图3为本发明实施例提供的纳米纤维膜的实物图。图中,F为25%Z+25%ZCR,G为负载了姜黄素和白藜芦醇的SPI+25%ZCR,H、I为SPI。Figure 3 is a physical diagram of the nanofiber membrane provided by the embodiment of the present invention. In the figure, F is 25%Z+25%ZCR, G is SPI+25%ZCR loaded with curcumin and resveratrol, and H and I are SPI.

图4为本发明实施例提供的不同纳米纤维膜的傅里叶红外光谱图。Figure 4 is a Fourier transform infrared spectrum chart of different nanofiber membranes provided by embodiments of the present invention.

图5为本发明实施例提供的不同纳米纤维膜的DSC曲线图。Figure 5 is a DSC curve chart of different nanofiber membranes provided by embodiments of the present invention.

图6 为本发明实施例提供的纳米纤维膜的抗氧化性结果。Figure 6 shows the oxidation resistance results of the nanofiber membrane provided by the embodiment of the present invention.

图7为本发明实施例提供的纳米纤维膜的抗菌性结果。Figure 7 shows the antibacterial results of the nanofiber membrane provided by the embodiment of the present invention.

图8为本发明实施例提供的纳米纤维膜的体外释放结果。Figure 8 shows the in vitro release results of the nanofiber membrane provided by the embodiment of the present invention.

具体实施方式Detailed ways

为了使本领域的技术人员更好地理解本发明的技术方案,下面将结合实施例和附图对本发明作进一步的详细介绍。显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。In order to enable those skilled in the art to better understand the technical solution of the present invention, the present invention will be described in further detail below with reference to the embodiments and drawings. Obviously, the described embodiments are only some of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts fall within the scope of protection of the present invention.

下述实施例中的实验方法,如无特殊说明,均为常规方法。The experimental methods in the following examples are all conventional methods unless otherwise specified.

下述实施例中所用的试验材料,如无特殊说明,均为自常规生化试剂商店购买得到的。醇溶蛋白购自日本Wako。大豆分离蛋白购自上海源叶生物科技有限公司。姜黄素购自北京百灵威公司。白藜芦醇购自麦克林公司。The test materials used in the following examples were all purchased from conventional biochemical reagent stores unless otherwise specified. Prolamin was purchased from Wako, Japan. Soy protein isolate was purchased from Shanghai Yuanye Biotechnology Co., Ltd. Curcumin was purchased from Beijing Bailingwei Company. Resveratrol was purchased from McLean.

1、纺丝液的制备1. Preparation of spinning solution

(1)以六氟异丙醇为溶剂,将大豆分离蛋白(Spi)和聚氧化乙烯(PEO)按照质量比为1:1、2:1、4:1、8:1进行混合,在45℃于超声的条件下搅拌1天,使溶液充分溶解,并对其分别进行单轴静电纺丝,得到效果最好的大豆分离蛋白纳米纤维膜(Spi 和PEO质量比为 4:1)记为SPI。(1) Use hexafluoroisopropyl alcohol as the solvent, mix soy protein isolate (Spi) and polyethylene oxide (PEO) according to the mass ratio of 1:1, 2:1, 4:1, 8:1, and mix at 45 ℃ for 1 day under ultrasonic conditions to fully dissolve the solution, and perform uniaxial electrospinning on them respectively to obtain the best soy protein isolate nanofiber membrane (the mass ratio of Spi to PEO is 4:1), which is recorded as SPI.

(2)85%的乙醇水溶液为溶剂,制备以下溶液:a.25 wt%的玉米醇溶蛋白(Zein)溶液和13 wt%的PEO溶液;b.30wt%的玉米醇溶蛋白(Zein)溶液和13 wt%的PEO溶液;c.加入姜黄素和白藜芦醇乙醇溶液(10 mg/ml)的25 wt%的Zein溶液和13 wt%的PEO溶液;d.加入姜黄素和白藜芦醇乙醇溶液(10 mg/ml)的30 wt%的Zein溶液和13 wt%的PEO溶液。按照Zein:PEO的质量比1:1混合,在室温下搅拌2 h进行单轴静电纺丝,得到的纳米纤维膜分别记为25%Z、30%Z、25%ZCR和30%ZCR。(2) Using 85% ethanol aqueous solution as the solvent, prepare the following solutions: a. 25 wt% zein (Zein) solution and 13 wt% PEO solution; b. 30 wt% zein (Zein) solution and 13 wt% PEO solution; c. Add curcumin and resveratrol ethanol solution (10 mg/ml) to 25 wt% Zein solution and 13 wt% PEO solution; d. Add curcumin and resveratrol Alcoholic ethanolic solution (10 mg/ml) of 30 wt% Zein and 13 wt% PEO. Mix according to the mass ratio of Zein:PEO 1:1, stir at room temperature for 2 h for uniaxial electrospinning, and the obtained nanofiber membranes are recorded as 25%Z, 30%Z, 25%ZCR and 30%ZCR respectively.

(3)85%的乙醇水溶液为溶剂,制备25 wt%的Zein 溶液和13 wt%的PEO溶液。按照质量比1:1混合,在室温下搅拌30 min作为壳液。制备25 wt% Zein溶液,向其中添加姜黄素和白藜芦醇(10 mg/ml),室温混合搅拌5 min作为核液进行同轴静电纺丝,得到的纳米纤维膜记为25%Z+25%ZCR。(3) Using 85% ethanol aqueous solution as the solvent, prepare a 25 wt% Zein solution and a 13 wt% PEO solution. Mix according to the mass ratio of 1:1 and stir at room temperature for 30 min to form a shell liquid. Prepare a 25 wt% Zein solution, add curcumin and resveratrol (10 mg/ml) to it, mix and stir for 5 minutes at room temperature as the core liquid for coaxial electrospinning, and the resulting nanofiber membrane is recorded as 25%Z+ 25%ZCR.

(4)85%的乙醇水溶液为溶剂,制备30 wt%的Zein 溶液和13 wt%的PEO溶液。按照质量比1:1混合,在室温下搅拌30 min作为壳液。制备30 wt% Zein溶液,向其中添加姜黄素和白藜芦醇(10 mg/ml),室温混合搅拌5 min作为核液进行同轴静电纺丝,得到的纳米纤维膜记为30%Z+30%ZCR。(4) Using 85% ethanol aqueous solution as the solvent, prepare a 30 wt% Zein solution and a 13 wt% PEO solution. Mix according to the mass ratio of 1:1 and stir at room temperature for 30 min to form a shell liquid. Prepare a 30 wt% Zein solution, add curcumin and resveratrol (10 mg/ml), mix and stir at room temperature for 5 minutes as the core liquid for coaxial electrospinning, and the resulting nanofiber membrane is recorded as 30%Z+ 30%ZCR.

(5)以六氟异丙醇为溶剂,制备Spi:PEO质量比为4:1的溶液,在45℃于超声的条件下充分搅拌1天作为壳液。制备25 wt% Zein溶液,向其中添加姜黄素和白藜芦醇(10 mg/ml),室温混合搅拌5 min作为核液进行同轴静电纺丝,得到的纳米纤维膜记为SPI+25%ZCR。(5) Use hexafluoroisopropanol as the solvent to prepare a solution with a Spi:PEO mass ratio of 4:1, and stir it thoroughly for 1 day at 45°C under ultrasonic conditions to serve as a shell liquid. Prepare a 25 wt% Zein solution, add curcumin and resveratrol (10 mg/ml) to it, mix and stir for 5 minutes at room temperature as the core liquid for coaxial electrospinning, and the resulting nanofiber membrane is recorded as SPI+25% ZCR.

2、纺丝参数2. Spinning parameters

单轴静电纺丝的参数设置为流速1.5 mL/h,纺丝时间2 h,电压25 kv,转速1500r/min,接收距离10 cm,环境温度为25±2℃,湿度为50±5%。The parameters of uniaxial electrospinning were set as flow rate 1.5 mL/h, spinning time 2 h, voltage 25 kv, rotation speed 1500 r/min, receiving distance 10 cm, ambient temperature 25±2°C, and humidity 50±5%.

同轴静电纺丝的参数设置为壳液流速5 mL/h,核液流速2 mL/h,纺丝时间1 h,电压25 kv,转速1500 r/min,接收距离13 cm,环境温度为25±2℃,湿度为50±5%。The parameters of coaxial electrospinning are set as shell liquid flow rate 5 mL/h, core liquid flow rate 2 mL/h, spinning time 1 h, voltage 25 kv, rotation speed 1500 r/min, receiving distance 13 cm, and ambient temperature 25 ±2℃, humidity 50±5%.

3、扫描电子显微镜3. Scanning electron microscope

对纤维膜进行喷金以增强导电性获得更清晰的微观形貌。喷金后通过场发射环境扫描电子显微镜观察纳米纤维膜的微观形貌。The fiber membrane is sprayed with gold to enhance conductivity and obtain a clearer micromorphology. After gold spraying, the micromorphology of the nanofiber membrane was observed by field emission environmental scanning electron microscopy.

通过单轴静电纺丝制得的SPI和Zein纳米纤维膜的形貌图分别如图1中A和B所示。A 为SPI,B 为25%Z。以SPI和Zein两种蛋白质进行静电纺丝得到的纳米纤维均呈连续、无珠且不均匀的圆柱状。The morphology images of SPI and Zein nanofiber membranes prepared by uniaxial electrospinning are shown in Figure 1, A and B, respectively. A is SPI, B is 25%Z. The nanofibers obtained by electrospinning with two proteins, SPI and Zein, were continuous, bead-free and inhomogeneous cylindrical shapes.

通过同轴静电纺丝制得的25%Z+25%ZCR、30% Z+30%ZCR和SPI+25%ZCR纳米纤维膜的形貌图分别如图2中C、D和E所示。以不同蛋白质作为载体进行静电纺丝得到的纳米纤维均呈连续、无珠的带状,其中,通过同轴静电纺丝制得的25%Z+25%ZCR、30% Z+30%ZCR纳米纤维膜分布比较均匀,SPI+25%ZCR纳米纤维膜分布最均匀,且呈现出连续细长无间断的带状,表面更加光滑纤维直径分布较均一。25%Z+25%ZCR纳米纤维有轻微的缠结现象,且纤维直径分布不均一,推测可能是Zein浓度较低所导致。The morphology images of 25%Z+25%ZCR, 30% Z+30%ZCR and SPI+25%ZCR nanofiber membranes prepared by coaxial electrospinning are shown in Figure 2 C, D and E respectively. The nanofibers obtained by electrospinning with different proteins as carriers are all in the shape of continuous, bead-free ribbons. Among them, 25% Z+25% ZCR and 30% Z+30% ZCR nanofibers prepared by coaxial electrospinning The distribution of fiber membranes is relatively uniform, and the SPI+25%ZCR nanofiber membrane is the most uniformly distributed, showing a continuous, slender and uninterrupted ribbon shape, and the surface is smoother and the fiber diameter distribution is more uniform. The 25%Z+25%ZCR nanofibers are slightly entangled, and the fiber diameter distribution is uneven, which may be caused by the low Zein concentration.

如图3所示,25%Z+25%ZCR纳米纤维膜与锡纸有轻微粘连,较不易从锡纸上剥离,纳米纤维膜呈现较轻薄的丝绸状。SPI纳米纤维膜则不易从锡纸上剥离,剥离后呈现白色轻薄的带状。SPI+25%ZCR纳米纤维膜易从接收的锡纸上剥离,形成的纳米纤维膜似纸状。SPI对比于SPI+25%ZCR共混所制得的纳米纤维膜机械性能较差,不适合作为活性包装膜应用。同时,为了达到更好的纺丝效果,制备的纳米纤维膜作SPI+25%ZCR为食品包装材料更为稳定。As shown in Figure 3, the 25%Z+25%ZCR nanofiber membrane is slightly adherent to the tinfoil, and is difficult to peel off from the tinfoil. The nanofiber membrane appears light and thin like silk. The SPI nanofiber film is not easy to peel off from the tinfoil, and appears as a white, thin strip after peeling off. The SPI+25%ZCR nanofiber membrane is easy to peel off from the received tin foil, and the resulting nanofiber membrane looks like paper. Compared with SPI+25%ZCR blend, the nanofiber membrane produced by SPI has poor mechanical properties and is not suitable for use as an active packaging film. At the same time, in order to achieve better spinning effect, the prepared nanofiber membrane is made of SPI+25% ZCR and becomes a more stable food packaging material.

4、傅立叶变换红外光谱的测定4. Measurement of Fourier transform infrared spectrum

将纳米纤维膜与KBr按照1:100的比例混合,用研钵将样品与KBr研细成粉,压片1min成膜后放入仪器中进行测量。扫描范围4000~400 cm-1,其分辨率为4 cm-1,扫描32次条件下进行傅立叶变换叶红外光谱测量。测量时以溴化钾压片作为空白对照,所得红外图谱采用Origin软件进行分析。Mix the nanofiber membrane and KBr at a ratio of 1:100, grind the sample and KBr into powder in a mortar, press the film for 1 minute, and then put it into the instrument for measurement. The scanning range is 4000~400 cm -1 , the resolution is 4 cm -1 , and Fourier transform infrared spectrum measurement is performed under 32 scanning conditions. During the measurement, potassium bromide tablets were used as a blank control, and the obtained infrared spectrum was analyzed using Origin software.

通过对纳米纤维膜傅立叶变换红外光谱的测定,可以确定以Zein和PEO为核、大豆分离蛋白为壳的同轴纳米纤维膜是否成功制备,以及姜黄素、白藜芦醇是否成功负载在纳米纤维膜中。如图4所示,25%Z纳米纤维膜的特征峰在3415 cm-1、1639 cm-1和1544 cm-1处。当处于3415 cm-1时,可以观察到O-H的伸缩振动,而当处于1639 cm-1时,可以观察到C=O的拉伸,而当处于1544 cm-1时,可以观察到C-N的拉伸以及N-H的弯曲振动。SPI的特征峰在3409 cm-1、1650 cm-1,当处于3409 cm-1时,可以观察到O-H的伸缩振动,而当处于1650 cm-1时,可以观察到C=O的拉伸。当负载了姜黄素和白藜芦醇后,25%ZCR和SPI+25%ZCR的O-H峰移动到了3388和3335cm-1处。姜黄素的特征峰1601 cm-1、1205 cm-1,白藜芦醇(Res)的特征峰1383 cm-1、1152 cm-1在静电纺丝形成的纳米纤维膜中减少甚至消失,这可能与其被包裹有关。25%Z在3415 cm-1处的峰值在负载多酚后的纳米纤维膜中发生了移动,这表明多酚在纤维膜中存在。By measuring the Fourier transform infrared spectrum of the nanofiber membrane, it can be determined whether the coaxial nanofiber membrane with Zein and PEO as the core and soy protein isolate as the shell has been successfully prepared, and whether curcumin and resveratrol have been successfully loaded on the nanofibers. in the membrane. As shown in Figure 4, the characteristic peaks of the 25%Z nanofiber membrane are at 3415 cm -1 , 1639 cm -1 and 1544 cm -1 . When at 3415 cm -1 , the stretching vibration of OH can be observed, while at 1639 cm -1 , the stretching of C=O can be observed, and when at 1544 cm -1 , the stretching of CN can be observed Stretch and NH bending vibration. The characteristic peaks of SPI are at 3409 cm -1 and 1650 cm -1 . When it is at 3409 cm -1 , the stretching vibration of OH can be observed, and when it is at 1650 cm -1 , the stretching of C=O can be observed. When curcumin and resveratrol were loaded, the OH peaks of 25% ZCR and SPI+25% ZCR moved to 3388 and 3335 cm -1 . The characteristic peaks of curcumin at 1601 cm -1 and 1205 cm -1 and the characteristic peaks of resveratrol (Res) at 1383 cm -1 and 1152 cm -1 are reduced or even disappeared in the nanofiber membrane formed by electrospinning. This may be It has something to do with it being wrapped. The peak of 25%Z at 3415 cm -1 shifted in the nanofiber membrane after loading polyphenols, which indicated that polyphenols were present in the fiber membrane.

5、热稳定性的测定5. Determination of thermal stability

使用差式扫描量热仪(DSC)对单轴和同轴静电纺丝制备的纳米纤维薄膜进行测量。取样品量4 ~ 5 mg于铝盘中,压盖后放入DSC中,以空铝盘作为对照。测试条件:氮气氛围,流速50 mL/min,后以10℃/min的升温速率从20℃升至250℃。测试完成后使用TA仪器自带分析软件对样品热稳定性进行分析。Differential scanning calorimetry (DSC) was used to measure nanofiber films prepared by uniaxial and coaxial electrospinning. Take a sample of 4 ~ 5 mg in an aluminum pan, cover it and put it into DSC. Use an empty aluminum pan as a control. Test conditions: nitrogen atmosphere, flow rate 50 mL/min, and then rising from 20°C to 250°C at a heating rate of 10°C/min. After the test is completed, use the analysis software that comes with the TA instrument to analyze the thermal stability of the sample.

如图5所示,各纳米纤维膜的DSC曲线上都有一个明显的吸热峰,这是纳米纤维膜的热变性温度(Td)。单轴静电纺丝的纳米纤维膜SPI和30%Z的Td值分别为113.07℃和117.08℃,负载了Cur+Res的单轴纳米纤维膜30%ZCR的Td值增加为118.51℃,25%Z+25%ZCR和30%Z+30%ZCR的Td值接近。当壳溶液由Zein改变为SPI时,Td值大幅降低,降低了11.59%,Td越低代表膜组织结构被破坏时所需的热量越少。猜测Td值的降低可能是SPI与Zein相互作用的能量要低于Zein同轴静电纺丝的能量,降低了玉米醇溶蛋白的有序结构,导致纳米纤维膜的结构发生改变。As shown in Figure 5, there is an obvious endothermic peak on the DSC curve of each nanofiber membrane, which is the thermal denaturation temperature (Td) of the nanofiber membrane. The Td values of uniaxial electrospun nanofiber membranes SPI and 30%Z are 113.07℃ and 117.08℃ respectively. The Td values of uniaxial nanofiber membranes 30%ZCR loaded with Cur+Res increase to 118.51℃ and 25%Z. The Td values of +25%ZCR and 30%Z+30%ZCR are close. When the shell solution was changed from Zein to SPI, the Td value dropped significantly, by 11.59%. The lower the Td, the less heat is required to destroy the membrane structure. It is speculated that the decrease in Td value may be due to the fact that the energy of the interaction between SPI and Zein is lower than the energy of Zein coaxial electrospinning, which reduces the ordered structure of zein, resulting in a change in the structure of the nanofiber membrane.

6、抗氧化性的测定6. Determination of antioxidant properties

采用DPPH和ABTS两种自由基清除的方法考察不同的同轴纳米纤维膜的抗氧化性能。称取10 mg的纳米纤维膜于1 mL 85%的乙醇水溶液中室温摇晃1 h。Two free radical scavenging methods, DPPH and ABTS, were used to examine the antioxidant properties of different coaxial nanofiber membranes. Weigh 10 mg of the nanofiber membrane and shake it in 1 mL of 85% ethanol aqueous solution at room temperature for 1 h.

取样品上清液与0.1 mM的DPPH以1:30的比例混合,避光反应15 min。使用分光光度计在517 nm处记录吸光度。Take the sample supernatant and mix it with 0.1 mM DPPH in a ratio of 1:30, and react in the dark for 15 minutes. Record the absorbance at 517 nm using a spectrophotometer.

将ABTS(水溶7 mM)与过硫酸钾(水溶2.45 mM)1:1混合,室温避光放置12 h。取样品上清液与ABTS稀释液以1:20的比例混合,避光反应15 min。使用分光光度计在734 nm处记录吸光度。Mix ABTS (water-soluble 7 mM) and potassium persulfate (water-soluble 2.45 mM) at a ratio of 1:1 and place at room temperature in the dark for 12 h. Mix the sample supernatant and ABTS diluent at a ratio of 1:20 and react in the dark for 15 minutes. Record the absorbance at 734 nm using a spectrophotometer.

分别以不添加纳米纤维膜的DPPH和ABTS溶液做空白对照,每个样品做三组平行,使用以下公式计算自由基清除能力:DPPH and ABTS solutions without adding nanofiber membrane were used as blank controls respectively. Three parallel groups were made for each sample, and the free radical scavenging ability was calculated using the following formula:

其中Ac为对照品吸光度值,As为样品吸光度值。Among them, Ac is the absorbance value of the reference substance, and As is the absorbance value of the sample.

计算结果如图6所示。结果显示只含有SPI的纳米纤维膜对DPPH自由基的清除率为19.99%,对ABTS自由基清除率比较低,表现出较弱的抗氧化性。30%Z的纳米纤维膜中,具有较强的抗氧化能力,能够有效清除DPPH自由基,清除率高达16.01%,而ABTS自由基清除率则达到了60.63%。这是由于Zein自身具有抗氧化性能。30%ZCR表现出了优秀的自由基清除能力,同时经过同轴静电纺丝制成的纳米纤维膜SPI+25%ZCR、25Z+25%ZCR、30%Z+30%ZCR也表现出了较为优异的自由基清除能力,并且SPI+25%ZCR更为优异,确保大豆分离蛋白纤维薄膜在治疗创伤方面具有广阔的应用前景。The calculation results are shown in Figure 6. The results show that the nanofiber membrane containing only SPI has a scavenging rate of DPPH free radicals of 19.99%, and a relatively low scavenging rate of ABTS free radicals, showing weak antioxidant properties. The 30% Z nanofiber membrane has strong antioxidant capacity and can effectively scavenge DPPH free radicals with a scavenging rate of up to 16.01%, while the ABTS free radical scavenging rate has reached 60.63%. This is due to Zein's own antioxidant properties. 30%ZCR shows excellent free radical scavenging ability. At the same time, the nanofiber membranes SPI+25%ZCR, 25Z+25%ZCR, and 30%Z+30%ZCR made by coaxial electrospinning also show relatively good performance. Excellent free radical scavenging ability, and SPI+25% ZCR is even better, ensuring that the soy protein isolate fiber film has broad application prospects in treating wounds.

7、抗菌性能的测定7. Determination of antibacterial properties

采用琼脂平皿扩散法对纳米纤维膜对金黄色葡萄球菌(购于中国普通微生物菌种保藏管理中心,保藏号CGMCC1.1861)的抑菌性能进行评估。取100 μL菌液均匀的涂布在平板的Luria broth (LB)琼脂培养基上对金黄色葡萄球菌进行培养。使用打孔器将纳米纤维膜制成直径为6 mm的圆片,使用前在紫外灯下照射30 min达到消毒的目的。将消毒后的纳米纤维膜粘在平板的琼脂培养基涂层中,在37℃培养箱中孵育24 h,通过抑制区大小评价纳米纤维膜的抗菌性能。The agar plate diffusion method was used to evaluate the antibacterial performance of the nanofiber membrane against Staphylococcus aureus (purchased from China General Microbial Culture Collection and Management Center, preservation number CGMCC1.1861). Take 100 μL of bacterial liquid and spread it evenly on the Luria broth (LB) agar medium of the plate to culture Staphylococcus aureus. Use a hole punch to make the nanofiber membrane into a disc with a diameter of 6 mm, and irradiate it under a UV lamp for 30 minutes to achieve disinfection before use. The sterilized nanofiber membrane was adhered to the agar medium coating of the plate and incubated in a 37°C incubator for 24 h. The antibacterial performance of the nanofiber membrane was evaluated by the size of the inhibition zone.

结果如图7所示,当白藜芦醇和姜黄素添加量为0.0%时,纳米纤维膜附近没有抑菌圈出现,说明SPI和25%Z不具有抗菌性。而向其中加入2.0%的Cur和2.0%的Res时的SPI+25%ZCR纳米纤维膜附近有明显抑菌圈出现,说明负载Cur和Res的纳米纤维膜对金黄色葡萄球菌有抑制作用,且本发明中纳米纤维膜SPI+25%ZCR中抑菌效果较明显。The results are shown in Figure 7. When the added amounts of resveratrol and curcumin were 0.0%, no inhibition zone appeared near the nanofiber membrane, indicating that SPI and 25% Z did not have antibacterial properties. When 2.0% Cur and 2.0% Res were added to it, an obvious inhibition zone appeared near the SPI+25% ZCR nanofiber membrane, indicating that the nanofiber membrane loaded with Cur and Res has an inhibitory effect on Staphylococcus aureus, and In the present invention, the antibacterial effect of the nanofiber membrane SPI+25%ZCR is more obvious.

8、体外释放的测定8. Determination of in vitro release

本试验中以10%乙醇水溶液作为食品模拟液,研究在这种环境下的食品模拟液中对指定纳米纤维膜进行体外释放的研究。称取10 mg纳米纤维膜浸没于10 mL的食品模拟液中,于25℃储存。在一定时间间隔内(0.5 h、1 h、2 h、4h、6 h、8 h、10 h、12 h)进行离心(2000 rpm 2 min),离心后取出1 mL上清液使用可见分光光度计分别在330nm处测量吸光度,并将模拟液补足。通过绘制的标准曲线计算纤维膜中Cur、Res释放在食品模拟液中的浓度。每个纤维膜进行3次重复试验,结果取平均值。In this experiment, 10% ethanol aqueous solution was used as a food simulation liquid to study the in vitro release of the designated nanofiber membrane in the food simulation liquid in this environment. Weigh 10 mg of nanofiber membrane, immerse it in 10 mL of food simulation solution, and store at 25°C. Centrifuge (2000 rpm 2 min) at certain time intervals (0.5 h, 1 h, 2 h, 4 h, 6 h, 8 h, 10 h, 12 h). After centrifugation, take out 1 mL of the supernatant and use visible spectrophotometry. Measure the absorbance at 330nm with a meter respectively, and make up the simulated solution. Calculate the concentration of Cur and Res released from the fiber membrane in the food simulation solution by drawing a standard curve. Each fiber membrane was tested three times, and the results were averaged.

纳米纤维膜在食品模拟液中的释放结果如图8所示。初始阶段各种纳米纤维膜在食品模拟液中均发生了突释现象。其中30%ZCR在初期释放量最多,前2小时在食品缓释液中释放79.36%,之后表现出长时间的持续缓慢释放。4 h时,25%Z+25%ZCR和30%Z+30%ZCR在食品模拟液中释放百分比为60%左右,之后同样表现出较长时间的持续缓慢释放。而SPI+25%ZCR在食品环境中姜黄素的释放量随着时间的增加而逐渐释放,在12h时表现出最高的释放率87.11%。The release results of the nanofiber membrane in food simulation liquid are shown in Figure 8. In the initial stage, burst release of various nanofiber membranes occurred in the food simulation liquid. Among them, 30% ZCR released the most in the initial stage, releasing 79.36% in the food sustained-release solution in the first 2 hours, and then showed a long-term sustained slow release. At 4 h, the release percentage of 25%Z+25%ZCR and 30%Z+30%ZCR in the food simulation solution was about 60%, and then also showed a sustained slow release for a long time. The release of curcumin from SPI+25% ZCR in the food environment gradually increased with time, showing the highest release rate of 87.11% at 12 hours.

综合以上实验结果,我们得出以下结论:Based on the above experimental results, we draw the following conclusions:

(1)经过单轴和双轴静电纺丝技术制备的Zein基纳米纤维膜,其中具有不同的核壳结构,而经过SEM技术检测,发现SPI-Zein蛋白基聚集体所制备的纳米纤维膜表面光滑,且直径分布均匀,具有良好的力学性能。(1) Zein-based nanofiber membranes prepared by uniaxial and biaxial electrospinning technology have different core-shell structures. After SEM technology inspection, it was found that the surface of the nanofiber membrane prepared by SPI-Zein protein-based aggregates Smooth, evenly distributed in diameter, and has good mechanical properties.

(2)通过FTIR证实了纳米纤维膜中多酚的成功负载。25%Z在3415 cm-1处的峰值在负载多酚后的纳米纤维膜中发生了移动,这表明多酚在纤维膜中存在。(2) The successful loading of polyphenols in the nanofiber membrane was confirmed by FTIR. The peak of 25%Z at 3415 cm -1 shifted in the nanofiber membrane after loading polyphenols, which indicated that polyphenols were present in the fiber membrane.

(3)通过分析不同纳米纤维膜的热性能发现,当壳溶液由Zein改变为SPI时,Td值大幅降低,降低了11.59%,膜组织结构被破坏时所需的热量越少。(3) By analyzing the thermal properties of different nanofiber membranes, it was found that when the shell solution was changed from Zein to SPI, the Td value dropped significantly, by 11.59%, and less heat was required when the membrane structure was destroyed.

(4)负载多酚的纳米纤维膜具有抗氧化和抑制金黄色葡萄球菌的作用。只含有SPI的纳米纤维膜和只含有Zein的纳米纤维膜具有一定的抗氧化性,但抗氧化性较弱。而通过同轴静电纺丝制成的纳米纤维膜SPI+25%ZCR、25%Z+25%ZCR、30%Z+30%ZCR表现出了较为优异的自由基清除能力,并且SPI+25%ZCR更为优异,抗菌效果也更加显著,在模拟体外释放时也表现出缓慢稳定的释放速度,性能更为优异。(4) Polyphenol-loaded nanofiber membranes have antioxidant and Staphylococcus aureus inhibitory effects. Nanofiber membranes containing only SPI and nanofiber membranes containing only Zein have certain antioxidant properties, but their antioxidant properties are weak. The nanofiber membranes SPI+25%ZCR, 25%Z+25%ZCR, and 30%Z+30%ZCR made by coaxial electrospinning show relatively excellent free radical scavenging capabilities, and SPI+25% ZCR is more excellent and has more significant antibacterial effect. It also shows a slow and stable release rate when simulating in vitro release, and its performance is even better.

以上只通过说明的方式描述了本发明的某些示范性实施例,毋庸置疑,对于本领域的普通技术人员,在不偏离本发明的精神和范围的情况下,可以用各种不同的方式对所描述的实施例进行修正。因此,上述附图和描述在本质上是说明性的,不应理解为对本发明权利要求保护范围的限制。Certain exemplary embodiments of the present invention have been described above only by way of illustration. It goes without saying that those skilled in the art can implement various embodiments in various ways without departing from the spirit and scope of the present invention. The described embodiments are modified. Therefore, the above drawings and descriptions are illustrative in nature and should not be construed as limiting the scope of the claims of the present invention.

Claims (4)

1.姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,其特征在于,将大豆分离蛋白和聚氧化乙烯混合溶液作为壳液,将添加姜黄素和白藜芦醇的玉米醇溶蛋白溶液作为核液,壳液和核液通过同轴静电纺丝得到姜黄素-白藜芦醇蛋白基纳米纤维膜;方法包括以下步骤:1. Preparation method of curcumin-resveratrol protein-based nanofiber membrane, characterized in that a mixed solution of soy protein isolate and polyethylene oxide is used as the shell liquid, and zein with curcumin and resveratrol is added The solution is used as the core liquid, and the shell liquid and the core liquid are coaxially electrospun to obtain a curcumin-resveratrol protein-based nanofiber membrane; the method includes the following steps: S1、以六氟异丙醇为溶剂,制备大豆分离蛋白:聚氧化乙烯质量比为4:1的溶液,超声搅拌使溶液充分溶解作为壳液,记为SPI;S1. Use hexafluoroisopropanol as the solvent to prepare a solution with a mass ratio of soy protein isolate:polyethylene oxide of 4:1. Stir ultrasonically to fully dissolve the solution as a shell liquid, which is recorded as SPI; S2、制备25 wt%玉米醇溶蛋白溶液,向其中添加姜黄素和白藜芦醇,姜黄素和白藜芦醇的添加量均为10 mg/ml,搅拌使溶液混合均匀作为核液;S2. Prepare a 25 wt% zein solution, add curcumin and resveratrol to it, the added amounts of curcumin and resveratrol are both 10 mg/ml, and stir until the solution is evenly mixed to serve as a nuclear liquid; S3、将壳液和核液进行同轴静电纺丝,得到姜黄素-白藜芦醇蛋白基纳米纤维膜,记为SPI+25%ZCR。S3. Perform coaxial electrospinning of the shell liquid and core liquid to obtain a curcumin-resveratrol protein-based nanofiber membrane, which is recorded as SPI+25%ZCR. 2.根据权利要求1所述的姜黄素-白藜芦醇蛋白基纳米纤维膜的制备方法,其特征在于,同轴静电纺丝的参数设置为:壳液流速5 mL/h,核液流速2 mL/h,纺丝时间1 h,电压25kv,转速1500 r/min,接收距离13 cm,环境温度为25±2℃,湿度为50±5%。2. The preparation method of curcumin-resveratrol protein-based nanofiber membrane according to claim 1, characterized in that the parameters of coaxial electrospinning are set to: shell liquid flow rate 5 mL/h, core liquid flow rate 2 mL/h, spinning time 1 h, voltage 25kv, rotation speed 1500 r/min, receiving distance 13 cm, ambient temperature 25±2℃, humidity 50±5%. 3.姜黄素-白藜芦醇蛋白基纳米纤维膜,其特征在于,采用权利要求1~2任一项所述的方法制成。3. Curcumin-resveratrol protein-based nanofiber membrane, characterized in that it is made by the method described in any one of claims 1 to 2. 4.根据权利要求3所述的姜黄素-白藜芦醇蛋白基纳米纤维膜在创伤敷料方面的应用。4. Application of the curcumin-resveratrol protein-based nanofiber membrane according to claim 3 in wound dressings.
CN202310800257.4A 2023-07-03 2023-07-03 Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application Active CN116516575B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202310800257.4A CN116516575B (en) 2023-07-03 2023-07-03 Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application
ZA2024/04467A ZA202404467B (en) 2023-07-03 2024-06-10 A curcumin-resveratrol protein-based nanofiber film, a preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310800257.4A CN116516575B (en) 2023-07-03 2023-07-03 Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application

Publications (2)

Publication Number Publication Date
CN116516575A CN116516575A (en) 2023-08-01
CN116516575B true CN116516575B (en) 2023-09-19

Family

ID=87408610

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310800257.4A Active CN116516575B (en) 2023-07-03 2023-07-03 Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application

Country Status (2)

Country Link
CN (1) CN116516575B (en)
ZA (1) ZA202404467B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118141942B (en) * 2024-01-29 2024-10-01 中国农业大学 Carrier for improving curcumin colon utilization rate and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103282567A (en) * 2009-05-18 2013-09-04 康奈尔大学 Biodegradable nanofibers and implementations thereof
CN109260150A (en) * 2018-09-26 2019-01-25 同济大学 Core-shell Coaxial Nanofibers for repairing periodontitis bone defect and preparation method thereof and purposes
CN111733531A (en) * 2020-06-04 2020-10-02 中国制浆造纸研究院有限公司 Multifunctional mask and preparation method thereof
CN111850731A (en) * 2020-07-24 2020-10-30 吉林农业大学 Prolamin-based core-shell fiber membrane and food storage and preservation material and preparation method
EP3943071A1 (en) * 2020-03-31 2022-01-26 Zurab Durmischchanowitch Khinikadze Composition comprising natural lipophilic compounds, use of the composition and method for preparing the composition
CN115737596A (en) * 2022-12-06 2023-03-07 威海海洋生物医药产业技术研究院有限公司 Curcumin-resveratrol prolamin particle and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790921B2 (en) * 2007-02-14 2014-07-29 Drexel University Alimentary protein-based scaffolds (APS) for wound healing, regenerative medicine and drug discovery

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103282567A (en) * 2009-05-18 2013-09-04 康奈尔大学 Biodegradable nanofibers and implementations thereof
CN109260150A (en) * 2018-09-26 2019-01-25 同济大学 Core-shell Coaxial Nanofibers for repairing periodontitis bone defect and preparation method thereof and purposes
EP3943071A1 (en) * 2020-03-31 2022-01-26 Zurab Durmischchanowitch Khinikadze Composition comprising natural lipophilic compounds, use of the composition and method for preparing the composition
CN111733531A (en) * 2020-06-04 2020-10-02 中国制浆造纸研究院有限公司 Multifunctional mask and preparation method thereof
CN111850731A (en) * 2020-07-24 2020-10-30 吉林农业大学 Prolamin-based core-shell fiber membrane and food storage and preservation material and preparation method
CN115737596A (en) * 2022-12-06 2023-03-07 威海海洋生物医药产业技术研究院有限公司 Curcumin-resveratrol prolamin particle and preparation method thereof

Also Published As

Publication number Publication date
CN116516575A (en) 2023-08-01
ZA202404467B (en) 2024-09-25

Similar Documents

Publication Publication Date Title
Duan et al. Development and characterization of electrospun nanofibers based on pullulan/chitin nanofibers containing curcumin and anthocyanins for active-intelligent food packaging
Feng et al. A novel route for double-layered encapsulation of probiotics with improved viability under adverse conditions
Lin et al. Preparation of ε-polylysine/chitosan nanofibers for food packaging against Salmonella on chicken
Horuz et al. Nanoencapsulation of carotenoids extracted from tomato peels into zein fibers by electrospinning
Lin et al. Moringa oil/chitosan nanoparticles embedded gelatin nanofibers for food packaging against Listeria monocytogenes and Staphylococcus aureus on cheese
He et al. Biodegradable and antimicrobial CSC films containing cinnamon essential oil for preservation applications
Ansarifar et al. Preservation of strawberry fruit quality via the use of active packaging with encapsulated thyme essential oil in zein nanofiber film
Jiang et al. Electrospun zein/polyoxyethylene core-sheath ultrathin fibers and their antibacterial food packaging applications
Zhou et al. Active packaging based on swim bladder gelatin/galangal root oil nanofibers: Preparation, properties and antibacterial application
Li et al. Electrospun phospholipid nanofibers encapsulated with cinnamaldehyde/HP-β-CD inclusion complex as a novel food packaging material
Zhou et al. Electrospun gelatin/tea polyphenol@ pullulan nanofibers for fast‐dissolving antibacterial and antioxidant applications
Nazari et al. An eco-friendly chitosan/cellulose acetate hybrid nanostructure containing Ziziphora clinopodioides essential oils for active food packaging applications
Bahrami et al. Bioactive gliadin electrospinning loaded with Zataria multiflora Boiss essential oil: Improves antimicrobial activity and release modeling behavior
CN116516575B (en) Curcumin-resveratrol protein-based nanofiber membrane and its preparation method and application
Liu et al. Self-assembled carboxymethyl chitosan/zinc alginate composite film with excellent water resistant and antimicrobial properties for chilled meat preservation
Rodríguez-Sánchez et al. Electrospinning of ultra-thin membranes with incorporation of antimicrobial agents for applications in active packaging: a review
Chen et al. Novel bioactive sponge mats composed of oxidized bacterial cellulose and chitosan-gum Arabic microcapsules loaded with cinnamon essential oil for enhancing meat preservation
Shanbehzadeh et al. Fabrication and characterization of electrospun nanofibrous mats of polycaprolactone/gelatin containing ZnO nanoparticles and cumin essential oil and their anti-staphylococcal potency in white cheese
Shen et al. Carboxymethyl chitosan and polycaprolactone-based rapid in-situ packaging for fruit preservation by solution blow spinning
Wardhani et al. Physical–chemical crosslinked electrospun Colocasia esculenta tuber protein–chitosan–poly (ethylene oxide) nanofibers with antibacterial activity and cytocompatibility
US20230193514A1 (en) Probiotic-encapsulating gum arabic composite fiber/capsule, preparation method and application thereof
Nambiar et al. The use of chitosan in food packaging applications
Huang et al. Lactobacillus bulgaricus-loaded and chia mucilage-rich gum arabic/pullulan nanofiber film: An effective antibacterial film for the preservation of fresh beef
Pouralkhas et al. Physicochemical and functional characterization of gelatin edible film incorporated with fucoidan isolated from Sargassum tenerrimum
Allafchian et al. Design of polysaccharidic Aloe vera gel incorporated PVA/tetracycline electrospun cell culture scaffolds for biomedical applications

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant